Lower mRNA levels of SSTR2 were expressed in the metastases from prostate cancers than in primary prostate cancers, meanwhile, decreased SSTR2 could predict poor prognosis of prostate cancer [35]. This evidence concerns the gene SSTR2 and Familial prostate cancer.